The medicine cabinet: What's in it, why, and can we change the contents?

Thomas W. Croghan; Patricia M. Pittman

doi:10.1377/hlthaff.23.1.23

The medicine cabinet: What's in it, why, and can we change the contents?

Thomas W. Croghan, Patricia M. Pittman

Research output: Contribution to journal › Review article › peer-review

12 Scopus citations

Abstract

The failure of the pharmaceutical industry to produce drugs for common chronic diseases, emerging diseases, and the potential threats of bioterrorism or the spread of tropical diseases contrasts sharply with the industry's output of lifestyle and "me-too" drugs. In this paper we review the decision-making process that resulted in our current portfolio of medicines and offer several alternatives to better align business incentives with medical need.

Original language	English (US)
Pages (from-to)	23-33
Number of pages	11
Journal	Health Affairs
Volume	23
Issue number	1
DOIs	https://doi.org/10.1377/hlthaff.23.1.23
State	Published - Jan 2004
Externally published	Yes

ASJC Scopus subject areas

General Medicine

Access to Document

10.1377/hlthaff.23.1.23

Cite this

@article{9e8579caaffb44b085280e7d4224d70d,

title = "The medicine cabinet: What's in it, why, and can we change the contents?",

abstract = "The failure of the pharmaceutical industry to produce drugs for common chronic diseases, emerging diseases, and the potential threats of bioterrorism or the spread of tropical diseases contrasts sharply with the industry's output of lifestyle and {"}me-too{"} drugs. In this paper we review the decision-making process that resulted in our current portfolio of medicines and offer several alternatives to better align business incentives with medical need.",

author = "Croghan, {Thomas W.} and Pittman, {Patricia M.}",

year = "2004",

month = jan,

doi = "10.1377/hlthaff.23.1.23",

language = "English (US)",

volume = "23",

pages = "23--33",

journal = "Health Affairs",

issn = "0278-2715",

publisher = "Project Hope",

number = "1",

}

TY - JOUR

T1 - The medicine cabinet

T2 - What's in it, why, and can we change the contents?

AU - Croghan, Thomas W.

AU - Pittman, Patricia M.

PY - 2004/1

Y1 - 2004/1

N2 - The failure of the pharmaceutical industry to produce drugs for common chronic diseases, emerging diseases, and the potential threats of bioterrorism or the spread of tropical diseases contrasts sharply with the industry's output of lifestyle and "me-too" drugs. In this paper we review the decision-making process that resulted in our current portfolio of medicines and offer several alternatives to better align business incentives with medical need.

AB - The failure of the pharmaceutical industry to produce drugs for common chronic diseases, emerging diseases, and the potential threats of bioterrorism or the spread of tropical diseases contrasts sharply with the industry's output of lifestyle and "me-too" drugs. In this paper we review the decision-making process that resulted in our current portfolio of medicines and offer several alternatives to better align business incentives with medical need.

UR - http://www.scopus.com/inward/record.url?scp=4243148517&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4243148517&partnerID=8YFLogxK

U2 - 10.1377/hlthaff.23.1.23

DO - 10.1377/hlthaff.23.1.23

M3 - Review article

C2 - 15002625

AN - SCOPUS:4243148517

SN - 0278-2715

VL - 23

SP - 23

EP - 33

JO - Health Affairs

JF - Health Affairs

IS - 1

ER -

The medicine cabinet: What's in it, why, and can we change the contents?

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this